GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Cash, Cash Equivalents, Marketable Securities

Sona Nanotech (XCNQ:SONA) Cash, Cash Equivalents, Marketable Securities : C$1.45 Mil (As of Jan. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Cash, Cash Equivalents, Marketable Securities?

Sona Nanotech's quarterly cash, cash equivalents, marketable securities increased from Jul. 2024 (C$0.02 Mil) to Oct. 2024 (C$1.86 Mil) but then stayed the same from Oct. 2024 (C$1.86 Mil) to Jan. 2025 (C$1.45 Mil).

Sona Nanotech's annual cash, cash equivalents, marketable securities declined from Oct. 2022 (C$0.16 Mil) to Oct. 2023 (C$0.12 Mil) but then increased from Oct. 2023 (C$0.12 Mil) to Oct. 2024 (C$1.86 Mil).


Sona Nanotech Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Sona Nanotech's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Cash, Cash Equivalents, Marketable Securities Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 1.20 0.16 0.12 1.86

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.03 0.02 1.86 1.45

Sona Nanotech Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Sona Nanotech  (XCNQ:SONA) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Sona Nanotech Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Industry
Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines